Medexus Pharmaceuticals Inc. (MEDXF)

Medexus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 29, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	67	54	29	24	50	120
Market Cap Growth	45.28%	86.77%	21.85%	-52.44%	-58.30%	390.26%
Enterprise Value	80	86	72	80	94	162
Last Close Price	2.05	1.66	1.22	1.19	2.51	6.30
PE Ratio	83.37	24.17	-	19.55	-	-
PS Ratio	0.64	0.50	0.26	0.22	0.65	1.51
PB Ratio	1.27	1.04	0.96	1.06	2.82	6.68
P/FCF Ratio	3.45	2.28	1.56	-	-	24.45
P/OCF Ratio	3.40	2.26	1.55	-	-	23.88
EV/Sales Ratio	0.77	0.79	0.64	0.74	1.23	2.04
EV/EBITDA Ratio	4.87	4.53	3.91	5.59	-	25.52
EV/EBIT Ratio	9.60	7.20	5.64	9.46	-	221.81
EV/FCF Ratio	4.08	3.60	3.86	-	-	32.94
Debt / Equity Ratio	0.41	0.71	1.65	3.12	3.08	2.49
Debt / EBITDA Ratio	1.32	1.95	2.68	4.81	-	6.69
Debt / FCF Ratio	1.12	1.56	2.67	-	-	9.12
Asset Turnover	0.70	0.66	0.71	0.72	0.53	0.59
Inventory Turnover	1.18	1.17	1.61	1.92	1.83	2.24
Quick Ratio	0.28	0.38	0.44	0.43	0.51	0.94
Current Ratio	0.81	0.83	1.10	0.87	1.02	1.47
Return on Equity (ROE)	1.88%	5.45%	-0.81%	6.07%	-16.08%	-133.66%
Return on Assets (ROA)	3.50%	4.55%	5.04%	3.53%	-5.38%	0.34%
Return on Capital (ROIC)	6.84%	8.79%	9.25%	6.42%	-11.41%	0.73%
Return on Capital Employed (ROCE)	11.30%	16.00%	14.30%	10.90%	-	0.70%
Earnings Yield	1.20%	4.14%	-0.74%	5.12%	-5.74%	-23.48%
FCF Yield	28.99%	43.91%	64.18%	-6.31%	-2.54%	4.09%
Buyback Yield / Dilution	-21.73%	-18.76%	-8.76%	-3.36%	-30.65%	-5.83%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.